MedTrace Logo

Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction

NCT02356965 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-03-26

No results posted yet for this study

Summary

The purpose of the study is to test two different doses of ketamine sub-lingual (under the tongue) wafer against placebo to see how effective the medication is to treat moderate to severe pain after wisdom tooth extraction.

Conditions

Interventions

DRUG

Ketamine

Single dose of sublingual investigational medication administered when subjects develop moderate to severe pain after third molar extraction.

DRUG

Placebo (for Ketamine)

Sublingual sugar pill developed to mimic ketamine sublingual dose.

Sponsors & Collaborators

  • Jean Brown Research

    collaborator OTHER

  • Lotus Clinical Research, LLC

    collaborator OTHER

  • iX Biopharma Ltd.

    lead OTHER

Principal Investigators

  • Derek D Muse, MD · Jean Brown Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02356965 on ClinicalTrials.gov